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Anosognosia, or unawareness of one’s own cognitive deﬁcits, may cause issues when measuring perceived stress and cortisol
levels in Alzheimer’s disease (AD) and Mild Cognitive Impairment (MCI). The goal of this study was to examine the eﬀects of
anosognosia on perceived stress and salivary cortisol levels in normal elderly (NE) adults, MCI individuals, newly diagnosed
AD patients, and long-lasting AD patients, suspected to show more anosognosia. An anosognosia index for perceived stress was
computed by subtracting the score on the Perceived Stress Scale measured in the participants and their relative. Cortisol levels were
measured four times a day over two nonconsecutive days. Greater anosognosia for dementia correlated with greater anosognosia
forperceivedstressinthegroupasawhole.However,nocorrelationbetweencortisollevelsandeitheranosognosiafordementiaor
perceivedstresswasobserved.OurresultssuggestthatmeasuringperceivedstressinADpatientsmaybeinﬂuencedbyanosognosia.
1.Introduction
Cortisol is a hormone secreted when one faces a physical or
a psychological stressor. As such, cortisol is conceived as a
physiological marker of stress. When a stressor is perceived,
the hypothalamo-pituitary-adrenal (HPA) axis is activated,
the end product of which is the secretion of cortisol from the
adrenal glands. Four psychological determinants have been
shown to lead to the activation of the HPA axis and the
secretion of cortisol: novelty, unpredictability, threat to self,
and sense of loss of control [1]. Not everyone is sensitive to
the same extent to each of these factors, but essentially, the
more there are of these factors in any given situation, the
more likely one will perceive the situation as stressful and the
greater will be the secretion of cortisol [2].
Living with a diagnosis of Alzheimer’s disease (AD) is
especially stressful for the patients and their family and
encompasses many, if not all, of the psychological determi-
nants of a stress response. Indeed, in a review of qualitative
studies on the impact of living with early dementia, Steeman
and colleagues [3] reported that the “memory losses often
threatensthepatients’security,autonomy,andsenseofbeing
ameaningfulmemberofsociety.”Theauthorsaddedthatthe
memory losses interfering with coping strategies may cause
“frustration, uncertainty, and fear.” Similar conclusions were
derived from a study by Clare and colleagues [4]. One would
think that receiving the diagnosis of AD would trigger such a
stress response. However, a group headed by Carpenter and
colleagues [5] found that disclosure of AD diagnosis did not
elicit signiﬁcant increases on the Geriatric Depression Scale
nor on the 20-item state version of the State-Trait Anxiety
Inventory.
One important distinction in the ﬁeld of human stress
research is that to be stressful, a situation has to be perceived
as such [6]. This brings us to an important limitation in
the measurement of stress in AD, namely, the question as
to whether AD patients are able to appraise their own level
of stress. Patients with AD, and to some extent individuals
with Mild Cognitive Impairment (MCI), often display an-
osognosia, or unawareness of their cognitive deﬁcits [7–9].2 International Journal of Alzheimer’s Disease
Themorethediseaseprogresses,themoreseveretheanosog-
nosia of the patients is [10]. It is therefore possible that AD
patients and MCI individuals, unable to acknowledge their
cognitive deﬁcits, may also be unable to appraise their own
stress.
Measures of perceived stress such as Cohen’s 10-item
Perceived Stress Scale (PSS-10) [11] have been used in the
normal elderly (NE) population, and norms have been al-
ready established [12]. To our knowledge only one study has
examined PSS-10 in AD patients. Wahbeh and colleagues
[13] found that AD patients and their caregivers did not
show signiﬁcantly higher perceived stress compared to older
adults. Consequently, norms have yet to be established for
AD patients and individuals with MCI.
Higher cortisol levels have been found to correlate with
increased perceived stress in some studies examining vari-
ous populations [14, 15] but not in other studies [16–18].
Wahbeh and colleagues [13] have measured the association
b e t w e e nc o r t i s o ll e v e l sa n dp e r c e i v e ds t r e s si nA Dp a t i e n t s ,
and found a positive trend between cortisol levels measured
at 30 minutes after awakening and the patients’ scores on
PSS-10. Although this result suggests that AD patients are
able to appraise stressors with the concomitant increase of
cortisol levels that is associated with this appraisal, it is not
clear at this point in the literature whether the apparition
of anosognosia that develops with the disease eliminates the
association between perceived stress and cortisol levels in
these populations. It is possible that with the progression of
the disease over time, more anosognosia surfaces, counter-
acting the expected increase in cortisol levels of increasingly
more advanced, and less insightful, AD patients.
There are many scales that measure anosognosia, such
as the Anosognosia Questionnaire-Dementia (ANO) [19].
Like in most scales assessing anosognosia, the discrepancy
between the scores of the participants and those of their
relativesonalistofcognitivedeﬁcitsitemsisusedasanindex
of anosognosia for dementia. It would be interesting to look
at a similar anosognosia index for perceived stress. To our
knowledge, this has not been done or published in the litera-
ture before.
The goal of this study was to examine the eﬀects of an-
osognosia on the psychological and physiological markers of
stress in Alzheimer’s disease. We wanted to examine this in
a full cognitive spectrum of older adults, including healthy
NE who have no anosognosia for dementia, MCI individuals
who are expected to have lower levels of anosognosia for
dementia, newly diagnosed AD patients, and AD patients
who had the diagnosis for a longer period, thus suspected to
show more anosognosia. We hypothesized that anosognosia
for dementia should correlate positively with anosognosia
for perceived stress and inversely correlate with cortisol
levels.
2. Methods
2.1. Subjects. A convenience sample of 20 MCI individuals
and 29 AD patients was recruited at the memory clinic of
the Jewish General Hospital, Montreal, Canada. In addition,
20 normal elderly (NE) subjects without memory loss were
recruited from the general population. Each participant un-
derwent a battery of neuropsychological tests carried out by
neuropsychologists or trained research assistants. CT scans
were performed to rule out any organic cause of cognitive
dysfunction. A diagnosis of MCI or AD was made by con-
sensus at clinical meetings composed of neurologists, nurses,
geriatricians, and neuropsychologists who attended to the
patients.
ClinicalcriteriaforMCIwerethoseproposedbyPetersen
and colleagues [20]: (1) having subjective memory com-
plaints, (2) small but measurable deﬁcits (usually at least 1 to
1.5standarddeviationsbelownorms)onneuropsychological
tests adjusted for age and education, (3) lack of signiﬁcant
functional or social impairment, and (4) not meeting criteria
for dementia. For a diagnosis of AD, the clinical criteria
were those of the NINCDS-ADRDS [21]. We considered a
participanttohavenewlydiagnosedAD,labeled“newAD,”if
the diagnosis occurred within the past six months of testing;
consequently, participants who have had AD for longer than
six months were considered as having long-standing AD,
hereafter labeled “old AD.” The distinction from new AD
and old AD is based on the fact that old AD patients are
hypothesized to have higher anosognosia for dementia, and
possibly for perceived stress, as well as to have more time to
adjust to a new diagnosis of AD. Exclusion criteria were the
presence of other organic or psychiatric disorder that could
account for the cognitive deﬁcits in MCI and AD patients,
and the presence of any cognitive deﬁcits in NE.
Each participant had to designate an individual in their
immediate social circle (a friend, a spouse, a child, or a car-
egiver, hereafter referred to as a relative) to participate in the
study. Medical charts reviews were carried out to determine
the participants’ medications that could aﬀect cortisol and
perceived stress ratings. Informed consent was received from
every participant and their relative, and the protocol was
approved by Research Ethic Board of the Jewish General
Hospital, Montreal, Canada.
2.2.AnosognosiaIndexforDementia(ANO). TheAnosogno-
sia Questionnaire-dementia (ANO), [19]w a sg i v e nt oe a c h
participant. This questionnaire has been validated and con-
sistsof30itemsassessingone’smemory,dailylife,andbehav-
ioral and psychological symptoms on four-point scales. Both
theparticipant’sversionandtherelative’sversionoftheques-
tionnaire asked the same questions about the participant; the
diﬀerence in the scores between these versions was then used
as an index of anosognosia for dementia. The greater is the
diﬀerence in the score of the AD patient and the relative on
the scale, the greater is the anosognosia index assigned to the
AD patient.
2.3. Anosognosia Index for Perceived Stress (PSS). The 10-
itemPerceivedStressScale(PSS-10)[11]wasadministeredto
every participant and their relative. It constitutes one of the
most widely used quantitative questionnaires on perceived
stress and measures the stress perceived by an adult over
the previous month. An index of anosognosia for perceived
stress was devised by subtracting the score of the participantInternational Journal of Alzheimer’s Disease 3
from that of their relative, in a manner similar to how we
obtained the index of anosognosia for dementia: PSS = PSS-
10relative −PSS-10participant.Abouthalfoftheparticipants and
their relatives were given an incomplete version of the PSS-
10 on the ﬁrst visit (measurement error), resulting in two
missing items for about 40% of the study sample, making
comparisons with norms diﬃcult. An adjusted score out of
10 was computed from the score out of 8 for every subject.
2.4. Salivary Cortisol Levels. Participants were instructed to
collect four samples of saliva per day on two nonconsecutive
days. The four samples were taken upon awakening, 30 mi-
nutes after awakening, at 2PM, and at bedtime and com-
prised passive drool collected in plastic tubes. The partici-
pants and/or caregivers were then instructed to write down
the exact time, report any unusual event that might have
occurred before the saliva collection, and rate the mood of
the participant on a log sheet. We asked the participants
and/or their caregivers to subsequently store the saliva sam-
ples in their freezer to prevent degradation until they could
be collected for analysis. Radioimmunoassays were per-
formed at the Douglas Institute of Mental Health, Montreal,
Canada. Saliva measured for the four collection times were
averaged across the two days, controlling for the day-to-day
variation in cortisol secretion.
2.5. Procedure. The participants’ and relatives’ versions of
both the anosognosia and the PSS-10 questionnaires were
administered at the ﬁrst home visit, along with the instruc-
tions for the salivary collection. About two weeks after the
ﬁrstvisit,asecondappointmentwasscheduledtopickupthe
saliva samples. At the same time the Mini-Mental State Eval-
uation (MMSE) [22] and Montreal Cognitive Assessment
(MoCA) [23] were given to measure the cognitive function
of the participants.
2.6. Statistical Analyses. Multiple analyses of variance
(ANOVAs) and Pearson’s correlations were carried out using
SPSS version 16.0 (SPSS Inc., Chicago, IL).
3. Results
From November 2009 to January 2010, a total of 22 NE,
21 MCI individuals, 12 new AD patients (who received a
diagnosis of AD within the past six months), and 16 old
AD patients (who received a diagnosis of AD earlier than
the past six months) and their relatives agreed to participate
in the study. There were no diﬀerences in age, education,
or gender between the participants included and the initial
bigger cohort, nor between the participants for whom we
have a perceived stress score out of 10 and those for whom
we have a perceived stress score out of 8. We found very
strong correlations between scores out of 10 and scores out
of 8 for the participants on whom we had complete PSS-
10 questionnaires (r = 0.98, P<0.01, n = 43), sug-
gesting that the two missing items for half of the sample
had no major impact, allowing us to perform the intended
analyses. One old AD participant was excluded from the
Table 1: Demographic information for the normal elderly, individ-
uals with Mild Cognitive Impairement, newly diagnosed, and long-
lasting Alzheimer’s disease patients.
NE MCI New AD Old AD
Age 77.7 (1.3) 77.1 (1.3) 80.0 (0.8) 77.9 (1.4)
Education 15.2 (0.6) 15.9 (1.0) 13.1 (1.6) 13.9 (1.3)
Gender
(M:W)∗ 9:13 14:7 7:5 14:2
MMSE∗ 28.7 (1.4) 27.8 (2.0) 26.0 (1.9) 20.1 (5.9)
MoCA∗ 27.2 (0.6) 23.5 (0.7) 19.1 (1.7) 14.8 (1.4)
PSS-10 adjusted
Participant 7.6 (0.92) 12.6 (1.4) 8.8 (1.7) 10.2 (8.0)
Relative∗ 9.3 (1.5) 11.3 (6.3) 15.1 (7.4) 19.2 (6.7)
ANO∗ −0.5 (1.2) 1.0 (2.1) 10.9 (1.7) 19.2 (3.8)
This table represents the mean (standard error of the mean) and men
to women ratio (M:W) for the 22 normal elderly (NE), 21 individuals
with Mild Cognitive Impairment (MCI), 12 newly diagnosed Alzheimer’s
disease patients (new AD), and 17 long-lasting Alzheimer’s disease patients
(old AD). Age and education are in years. MMSE stands for Mini-Mental
State Evaluation; MoCA stands for Montreal Cognitive Assessment, PSS-10
adjusted stands for 10-item Perceived Stress Scale out of 8, adjusted to a
score of 10, as reported by the participants themselves, and as reported by
their relatives; ANO stands for anosognosia for dementia score. ∗Denotes a
signiﬁcant group diﬀerence with a P-value less than 0.05.
analyses due to extreme levels of cortisol (more than 3 stand-
ard deviations above the mean for old AD group). A review
of concomitant medications amongst participants revealed
that more MCIs were on medication for diabetes than the
other groups (nNE = 0; nMCI = 5; nnewAD = 0; noldAD =
0), whereas more AD patients (both new and old) were on
sedatives/antidepressants (nNE = 1; nMCI = 1; nnewAD = 4;
noldAD = 5) and acetyl cholinesterase inhibitors (nNE = 0;
nMCI = 0; nnewAD = 6; noldAD = 8). There were no diﬀerences
indemographics,anosognosiafordementia,anosognosiafor
perceived stress, or cortisol between the MCI who were on
diabeticmedicationsandthosewhowerenot.Similarly,there
were no statistical diﬀerence in demographics, anosognosia
for dementia, PSS-10, anosognosia for perceived stress, or
cortisol between the AD who were on sedatives, antidepres-
sants, and/or acetyl cholinesterase inhibitor and those who
were not.
The participants in the four groups were similar in age
and education, but there were more women participants in
the NE group compared to the other groups (X2
3 = 8.8, P =
0.03). As expected, the groups diﬀered in MMSE and MoCA
scores (all P<0.01). Demographic information is presented
in Table 1.
There were no diﬀerences across the diagnostic groups
in the level of perceived stress (PSS-10) as reported by
the participants (F(3,70) = 2.5, P = 0.07). There was a
trend, however, mainly driven by MCI who reported higher
perceived stress than the other groups (not signiﬁcant).
However, there were signiﬁcant diagnostic group diﬀerences
in the level of perceived stress (PSS-10) as reported by the
relatives (F(3,70) = 7.3, P<0.01). Posthoc analyses showed
that the relatives reported less stress for the NE participants4 International Journal of Alzheimer’s Disease
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Figure 1:Scoresonanosognosiafordementia,anosognosiaforper-
ceived stress, and cortisol levels in normal elderly, individuals with
Mild Cognitive Impairment, newly diagnosed, and long-lasting
Alzheimer’s disease patients. These graphs represent the scores on
anosognosia for dementia (ANO), anosognosia for perceived stress
(PSS), and cortisol levels (CORT, in μg/dL) in 21 normal elderly
(NE, black bars), 20 individuals with Mild Cognitive Impairment
(MCI, dark grey bars), 12 newly diagnosed (new AD, light grey
bars), and 17 long-lasting (old AD, white bars) Alzheimer’s disease
patients.
than for both new and old AD participants. In addition, the
relativesreportedlessstressfortheMCIparticipantsthanthe
old AD participants (all P<0.05).
The ANOVAs revealed statistically signiﬁcant group dif-
ferences in the anosognosia index for dementia (ANO,
F(3, 67) = 15.3, P<0.01). Post-hoc analyses, using
Bonferroni’s corrections, showed that the NE had lower
anosognosia for dementia (ANO) than new AD (P = 0.02)
and old AD (P<0.01) and that, similarly, the MCI had
lower anosognosia for dementia than new AD (P = 0.04)
and old AD (P<0.01). The ANOVAs revealed statistically
signiﬁcantgroupdiﬀerencesintheanosognosiaforperceived
stress (PSS, F(3, 67) = 6.15, P<0.01). Post-hoc analyses also
revealed that NE (P = 0.03) and MCI (P = 0.01) had lower
anosognosia for stress (PSS) than old AD. There were no
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Figure 2: Relationship between anosognosia for dementia and an-
osognosia for perceived stress in normal elderly, individuals with
Mild Cognitive Impairment, and Alzheimer’s disease patients. This
graph represents the lack of association between the scores on an-
osognosia for dementia (ANO) and on anosognosia for perceived
stress (PSS) in all the subjects. PSS is calculated as a diﬀerence score
on the PSS-10 as reported by the participants themselves versus the
PSS-10 as reported by their relatives.
group diﬀerence for cortisol level (F(3, 63) = 0.77, P = 0.51).
These results are presented in Figure 1.
To evaluate the association between the indices of ano-
sognosia for dementia (ANO) and anosognosia for perceived
stress (PSS), Pearson’s correlations were carried out. We
found a statistically signiﬁcant positive correlation between
the two scales across the groups (r = 051, P<0.01, n = 71;
see Figure 2) showing that greater anosognosia for dementia
wereassociatedwithgreateranosognosiaforperceivedstress.
Carrying these analyses in the diagnostic groups independ-
ently, we found a positive correlation between the two scales
in the NE only (r = 0.98, P<0.01, n = 22). When we
combined new and old AD together, we also found a positive
correlation between the two indices of anosognosia (r =
0.39, P = 0.04, n = 29).
To evaluate the association between cortisol levels and
the anosognosia indices for dementia and perceived stress,
we performed Pearson’s correlations across the diagnostic
groups. We did not ﬁnd any statistically signiﬁcant correla-
tions between cortisol levels and either the anosognosia in-
dex for dementia (ANO, r = 0.10, P = 0.42, n = 64) or
the anosognosia index for perceived stress (PSS, r =− 0.11,
P = 41, n = 64).
4. Discussion
This study investigated whether a lack of insight of one’s
memory deﬁcits correlates with one’s lack of insight for per-
ceived stress. Using targeted questionnaires, we found that
anindexofanosognosiafordementiacorrelatedsigniﬁcantly
with an index of anosognosia for perceived stress showing
that measuring perceived stress in AD, and possibly in MCI
individuals, may cause some problems due to the inability of
AD patients and some MCI individuals to acknowledge their
cognitive state.
Indeed, we found that AD patients, and more precisely
AD patients who have been diagnosed for a longer period ofInternational Journal of Alzheimer’s Disease 5
time, displayed more anosognosia for perceived stress than
NE or MCI individuals. Similarly, both newly diagnosed and
long-standing AD patients also showed greater anosognosia
for dementia than either NE or MCI individuals. These re-
sults are similar to ﬁndings in the literature, where AD pa-
tients showed anosognosia for dementia [7–9], but not MCI
individuals [24–27]. Although the diﬀerence between new
AD and old AD was not signiﬁcant in the anosognosia for
dementia scale, our results indicated that with the disease
progression and time, the severity of anosognosia for per-
ceived stress, and to some extend for dementia, increased.
Surprisingly, we did not ﬁnd group diﬀerences in cortisol
levels. This contradicts numerous previous studies (includ-
ing our own) that found diﬀerences between the cortisol
levels of NE and AD groups [28–32], and between NE and
MCI groups [32, 33]. The small sample size of this study,
paired with the high variability of cortisol measurements
across the days and seasons [32], almost certainly explains
the failure to ﬁnd statistically signiﬁcant group diﬀerences.
Another goal for this study was to examine the relation-
ship between anosognosia for dementia and perceived stress
with physiological marker of stress, namely, cortisol levels.
We did not ﬁnd an association between cortisol levels and
anosognosia for dementia, suggesting that anosognosia for
dementia does not aﬀect the levels of cortisol secreted by
the participants. Interestingly, we did not ﬁnd an association
between cortisol levels and anosognosia for perceived stress.
This adds to the body of literature that found no association
of cortisol and perceived stress in various populations [16–
18]. However, we did not ﬁnd the expected group diﬀer-
ences in cortisol secretion with progression of the disease,
preventing us from driving more in-depth conclusions on
the association, or lack thereof, between cortisol and ano-
sognosia for dementia or perceived stress.
Beside the small sample size, a few limitations need to
be addressed when interpreting our results. First, there were
more women in the NE group compared to the other groups,
especially when compared to AD patients. There exist gender
diﬀerences in stress [34, 35], and there exist gender by age
interaction eﬀects on cortisol levels in response to a stressor
[36]. Second, it is worth noting that more MCIs were treated
for diabetes, and diabetic individuals have been found to
secrete higher cortisol levels [37–39]. Third, and perhaps
most importantly, more AD patients (both new and old)
were on sedatives or antidepressants. These medications may
aﬀectthelevelofperceivedstressandthusexplaintherelative
anosognosia for perceived stress measured in these patients.
The limited number of participants with up-to-date medi-
cation information, especially in the NE, prevented us from
further conclusions regarding the eﬀect of medications in
this study. Finally, a subsample of the participants included
in this study had incomplete PSS-10 questionnaires, where
two items were missing. Although there was high correlation
between the complete version and the incomplete versions in
the individuals for which we had complete data, it remains
diﬃcult to assess whether the participants included in our
study had scores within the norms for older adults as sug-
gested by Cohen and Williamson [12]. When scores were
adjusted to a total of 10, the means of the four groups (see
Table 1) were within the suggested normal range (mean:
12.0 ± standard deviation: 6.3).
5. Conclusion
Despite these shortcomings, this study suggests that anosog-
nosia for dementia has an impact on psychological markers
of stress, but not on physiological markers of stress in Alz-
heimer’sdisease.Itisnecessarytoreplicatetheseﬁndingsina
larger sample while controlling for gender and, medications.
However our results suggest that measuring perceived stress
in AD patients may be inﬂuenced by the extent of anosog-
nosia and consequently, caution should be taken when as-
sessing association between perceived stress and cortisol
levels in these populations.
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